Please enable JS

Board of Directors

Robert Ingram
General Partner, Hatteras Venture Partners and Chairman, Viamet Pharmaceuticals

Jeffrey Edwards
Former Executive Vice President, Finance and Business Development and Chief Financial Officer, Allergan, Inc.

Andrew von Eschenbach, M.D.
Former Commissioner, U.S. Food and Drug Administration

Adrian Howd, Ph.D.
Chief Executive Officer, Malin Corporation plc.

Sean Murphy
Executive Vice President, Malin Corporation plc.

Douglas Reed, M.D.
General Partner, Hatteras Venture Partners

Robert Schotzinger, M.D., Ph.D.
President & Chief Executive Officer, Viamet Pharmaceuticals

S. Edward Torres
Managing Director, Lilly Ventures

Philip Tracy
Venture Partner, Intersouth Partners

Steven Weinstein
Managing Director, Novartis Venture Fund

Kristopher Wood
Chief Investment Officer, Lurie Holdings